As a crucial pro‐inflammatory cytokine, IL‐17A promotes HCC progression and is associated with HCC prognosis (Gu et al., 2011; Liao et al., 2013; Wu et al., 2012a; Zhang et al., 2009). Here, IL17A is linked to hepatocellular carcinoma.